Brief Title
Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care
Official Title
Adherence to NCCN Survivorship Care Guidelines in Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care
Brief Summary
This clinical trial studies adherence to survivorship care guidelines in health care
providers for non-small cell lung cancer or colorectal cancer survivor care. The completion
of an educational intervention by health care providers may increase compliance and adherence
to National Comprehensive Cancer Network guidelines for survivorship care.
Detailed Description
PRIMARY OBJECTIVES:
I. To evaluate adherence of oncology health care providers to National Comprehensive Cancer
Network (NCCN) guidelines for cancer survivorship care in colorectal cancer (CRC) and
non-small cell lung cancer (NSCLC) cancers.
SECONDARY OBJECTIVES:
I. To develop and assess a targeted educational initiative to improve compliance with NCCN
CRC and NSCLC survivorship guidelines for oncology health care providers in academic and
community practice.
II. To evaluate the impact of this educational initiative on documented adherence and
compliance with NCCN guidelines for NSCLC and CRC survivorship care by oncology health care
providers.
OUTLINE:
Health care providers complete an educational intervention based on NCCN guidelines in CRC
and NSCLC survivorship care comprising a power point presentation reviewing evidence and
guidelines; a USB drive of the NCCN guidelines with paper copy of pages addressing
survivorship care; an electronic and paper copy of a sample survivorship clinic template note
with prompts for addressing survivorship care components; and an electronic paper copy sample
survivorship care plan that can be adapted and distributed at each participating site.
Study Type
Interventional
Primary Outcome
Percentage of eligible CRC and NSCLC survivors with medical record documentation of compliance with NCCN guidelines
Secondary Outcome
Change in percentage of eligible survivors with documentation of compliance with NCCN survivorship guidelines after conducting the targeted educational initiative at participating sites
Condition
Adenocarcinoma of the Lung
Intervention
educational intervention
Study Arms / Comparison Groups
Health services research (educational intervention)
Description: Health care providers complete an educational intervention based on NCCN guidelines in CRC and NSCLC survivorship care comprising a power point presentation reviewing evidence and prompts for addressing survivorship care components; and an electronic paper copy sample survivorship care plan that can be adapted and distributed at each participating site.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Other
Estimated Enrollment
1440
Start Date
January 2013
Completion Date
July 2015
Primary Completion Date
July 2015
Eligibility Criteria
Inclusion Criteria:
- HEALTH CARE PROVIDER INCLUSION CRITERIA:
- Any health care provider (physician, advanced practice clinician) at a study site (Fox
Chase Cancer Center [FCCC] and Fox Chase Cancer Center Partners [FCCCP]) who provides
care for NSCLC and/or CRC survivors
- CHART AUDIT INCLUSION CRITERIA (BASELINE):
- Cancer Registry cases include stage I-III colon cancer (adenocarcinoma histology),
stage I-III rectal cancer (adenocarcinoma histology), stage I-III non-small cell lung
cancer (squamous or adenocarcinoma histology)
- Patients must have completed all therapy for curative intent at least six months prior
to chart audit
- Undergoing routine oncology care and surveillance at the chosen site (defined as
receiving follow-up care with FCCC or FCCCP site health care providers and have an
active medical chart)
- No evidence of metastatic disease
- Patients must have been seen for a visit for cancer surveillance between 2009 and 2013
- Health care providers at the participating site must be willing and able to
participate in the educational initiative
- CHART AUDIT INCLUSION CRITERIA (POST-INTERVENTION)
- Charts eligible for audit after completion of the educational initiative will be for
those CRC and NSCLC survivors presenting for follow-up after the initiative has been
completed by site health care providers
Exclusion Criteria:
- CHART AUDIT EXCLUSION CRITERIA:
- Cancer Registry cases for diseases other than colon or rectal adenocarcinoma and
non-small cell lung cancer (squamous or adenocarcinoma histology)
- Patients currently receiving active therapy for any cancer, including CRC or NSCLC
- Patients who do not undergo routine oncologic care at the chosen Partners site or Fox
Chase Cancer Center
- Stage IV cancer or evidence of metastatic disease at any time point
- Patients who have not undergone a visit for cancer surveillance since 2009
- Fox Chase Cancer Partners sites who do not agree to chart audit procedures or
providers are unable or unwilling to participate in the educational initiative
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Crystal Denlinger, MD, ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT01726296
Organization ID
12-841
Secondary IDs
NCI-2012-01717
Responsible Party
Sponsor
Study Sponsor
Fox Chase Cancer Center
Study Sponsor
Crystal Denlinger, MD, Principal Investigator, Fox Chase Cancer Center
Verification Date
November 2016